Cancer patients are highly susceptible to infections due to weakened immune systems from cancer and its treatments, and antibiotic-resistant bacteria make these infections harder to treat, leading to longer hospital stays and higher mortality rates.
A study conducted in India reviewed 440 cancer patients, finding that 48% had multidrug-resistant bacteria, with factors like surgery, chemotherapy, and severe neutropenia increasing infection risk.
The results indicated high mortality rates, particularly for patients with antibiotic-resistant infections, underscoring the need for tailored interventions, better infection control, and careful use of antibiotics to improve patient outcomes.